- Home
- MGTX vs RGR Comparison
MGTX vs RGR Comparison
Compare MGTX & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGTX
- RGR
- Stock Information
- Founded
- MGTX 2015
- RGR 1949
- Country
- MGTX United States
- RGR United States
- Employees
- MGTX N/A
- RGR N/A
- Industry
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- RGR Ordnance And Accessories
- Sector
- MGTX Health Care
- RGR Industrials
- Exchange
- MGTX Nasdaq
- RGR Nasdaq
- Market Cap
- MGTX 670.2M
- RGR 553.4M
- IPO Year
- MGTX N/A
- RGR N/A
- Fundamental
- Price
- MGTX $7.99
- RGR $39.32
- Analyst Decision
- MGTX Strong Buy
- RGR
- Analyst Count
- MGTX 2
- RGR 0
- Target Price
- MGTX $24.00
- RGR N/A
- AVG Volume (30 Days)
- MGTX 291.9K
- RGR 191.5K
- Earning Date
- MGTX 11-12-2025
- RGR 10-29-2025
- Dividend Yield
- MGTX N/A
- RGR 1.79%
- EPS Growth
- MGTX N/A
- RGR N/A
- EPS
- MGTX N/A
- RGR 0.35
- Revenue
- MGTX $37,917,000.00
- RGR $536,291,000.00
- Revenue This Year
- MGTX $145.67
- RGR N/A
- Revenue Next Year
- MGTX $167.61
- RGR $3.39
- P/E Ratio
- MGTX N/A
- RGR $113.31
- Revenue Growth
- MGTX 366.84
- RGR 3.31
- 52 Week Low
- MGTX $3.94
- RGR $31.64
- 52 Week High
- MGTX $8.98
- RGR $42.76
- Technical
- Relative Strength Index (RSI)
- MGTX 58.18
- RGR 77.29
- Support Level
- MGTX $7.21
- RGR $34.42
- Resistance Level
- MGTX $7.91
- RGR $39.97
- Average True Range (ATR)
- MGTX 0.38
- RGR 0.94
- MACD
- MGTX 0.03
- RGR 0.47
- Stochastic Oscillator
- MGTX 92.82
- RGR 88.61
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.